Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 drugs in development, 2023

MEEFRO December 8, 2023

0 0 Less than a minute

GlobalData’s report assesses the drugs in the Gamma-Aminobutyric Acid Receptor Subunit Alpha 2 pipeline by therapy areas, indications, stages, MoA, RoA, molecule type and the key players in the development pipeline.

Source link
#GammaAminobutyric #Acid #Receptor #Subunit #Alpha #drugs #development